Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8692 |
High Similarity |
NPD422 |
Phase 1 |
0.8433 |
Intermediate Similarity |
NPD2797 |
Approved |
0.8394 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8394 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8392 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8264 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8088 |
Intermediate Similarity |
NPD3225 |
Approved |
0.8085 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8085 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8042 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8041 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8029 |
Intermediate Similarity |
NPD3266 |
Approved |
0.8029 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7941 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7935 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7919 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7899 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7891 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7862 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7823 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7808 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7762 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7755 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7733 |
Intermediate Similarity |
NPD1511 |
Approved |
0.773 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7727 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7727 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7704 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7703 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7703 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7697 |
Intermediate Similarity |
NPD920 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7671 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7671 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7671 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7643 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7628 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7626 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7622 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7609 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7595 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7582 |
Intermediate Similarity |
NPD5403 |
Approved |
0.758 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7568 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7568 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7566 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7554 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7554 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7516 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3764 |
Approved |
0.75 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7466 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7452 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7445 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7436 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7417 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7379 |
Intermediate Similarity |
NPD411 |
Approved |
0.7379 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7361 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7358 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7343 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7343 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD37 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7338 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD17 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7319 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7312 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7312 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7289 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7241 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD6362 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7118 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD919 |
Approved |
0.7113 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7092 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2370 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7047 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7023 |
Intermediate Similarity |
NPD940 |
Approved |
0.7023 |
Intermediate Similarity |
NPD846 |
Approved |
0.7018 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7015 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7013 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD4622 |
Approved |
0.6987 |
Remote Similarity |
NPD6666 |
Approved |
0.6987 |
Remote Similarity |
NPD6667 |
Approved |
0.6971 |
Remote Similarity |
NPD4287 |
Approved |
0.6968 |
Remote Similarity |
NPD7003 |
Approved |
0.6968 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD1283 |
Approved |
0.6962 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD6273 |
Approved |
0.6959 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6944
|
Remote Similarity |
NPD9269 |
Phase 2 |